Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC |
WASCOE THOMAS MSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,643 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · derivative · entry 5 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,643 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC |
WASCOE THOMAS MSenior Vice President
|
Tax withholdingCommon shares without par value | 24,052 | $41.40 | $995,752.80 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · nonDerivative · entry 3 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,708 Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC |
WASCOE THOMAS MSenior Vice President
|
Exercise / conversionCommon shares without par value | 25,126 | $32.61 | $819,386.50 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · nonDerivative · entry 2 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2004 Filed Oct 25, 2004 22:09 UTC |
WASCOE THOMAS MSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,643 | $27.43 | $99,937.69 |
DisclosureSEC source: 0001104659-04-031745 · a4.xml · nonDerivative · entry 1 WASCOE THOMAS M · CIK 0001239130 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 2,612 | $0.00 Strike: $41.38 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 11 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,612 Underlying: Common Shares · 2,612 shares Expires 2007-02-13 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
GrantOption (right to buy) · Derivative | 2,988 | $0.00 Strike: $41.38 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 10 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,988 Underlying: Common Shares · 2,988 shares Expires 2006-02-08 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,941 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 9 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,941 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,022 | $0.00 Strike: $20.53 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,022 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,000 | $0.00 Strike: $18.39 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,661 Underlying: Common Shares · 1,000 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1991 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon Shares without par value | 6,044 | $41.38 | $250,100.72 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,063 Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon Shares without par value | 3,941 | $27.43 | $108,112.66 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon Shares without par value | 6,022 | $20.53 | $123,659.96 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC |
LINDER GREG WVice President
|
Exercise / conversionCommon Shares without par value | 1,000 | $18.39 | $18,391.90 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2004 Filed Oct 4, 2004 20:00 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 295 | $42.36 Strike: $0.00 | $12,496.20 |
DisclosureSEC source: 0001104659-04-029505 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,583 Underlying: common shares · 295 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2004 Filed Oct 4, 2004 20:00 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 542 | $42.36 Strike: $0.00 | $22,959.12 |
DisclosureSEC source: 0001104659-04-029506 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,578 Underlying: common shares · 542 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantOption (right to buy) · Derivative | 18,666 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,666 Underlying: Common shares · 18,666 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 21,280 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,562 Underlying: Common shares · 21,280 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC |
LIEPMANN HOLGER ASenior Vice President
|
SaleCommon shares without par value | 3,509 | $42.00 | $147,378.00 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,540 Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Tax withholdingCommon shares without par value | 18,666 | $41.69 | $778,185.54 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,049 Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionCommon shares without par value | 21,280 | $33.23 | $707,164.19 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 19:26 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
GrantOption (right to buy) · Derivative | 13,569 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001104659-04-026738 · a4.xml · derivative · entry 5 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,569 Underlying: common shares · 13,569 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 19:26 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 15,469 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-04-026738 · a4.xml · derivative · entry 4 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,050 Underlying: common shares · 15,469 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 19:26 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Tax withholdingCommon shares without par value | 13,569 | $41.69 | $565,691.61 |
DisclosureSEC source: 0001104659-04-026738 · a4.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,892 Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 19:26 UTC |
LEIDEN JEFFREY MDirector · President and COO
|
Exercise / conversionCommon shares without par value | 15,469 | $33.23 | $514,056.53 |
DisclosureSEC source: 0001104659-04-026738 · a4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC |
LIEPMANN HOLGER ASenior Vice President
|
GrantOption (right to buy) · Derivative | 8,761 | $0.00 Strike: $41.01 | $0.00 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,761 Underlying: Common shares · 8,761 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 10,284 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,284 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Tax withholdingCommon shares without par value | 8,761 | $41.01 | $359,288.61 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,435 Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC |
LIEPMANN HOLGER ASenior Vice President
|
Exercise / conversionCommon shares without par value | 10,284 | $32.61 | $335,372.55 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2004 Filed Aug 5, 2004 18:54 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001104659-04-022634 · a4.xml · derivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: common shares · 25,000 shares Expires 2014-08-02 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 8,334 on 8/03/05, 8,333 on 8/3/06 and 8,333 on 8/3/07. Read SEC document |
| August 01, 2004 Filed Aug 3, 2004 17:21 UTC |
Landgraf John CSenior Vice President
|
GrantCommon shares without par value | 3,500 | $39.24 | $137,340.00 |
DisclosureSEC source: 0001104659-04-021963 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,805 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| July 22, 2004 Filed Feb 1, 2005 17:21 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GiftCommon shares without par value | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,353 Read SEC document |
| June 30, 2004 Filed Jul 1, 2004 23:30 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 564 | $40.76 Strike: $0.00 | $22,988.64 |
DisclosureSEC source: 0001104659-04-018804 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,944 Underlying: common shares · 564 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · kind: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2004 Filed Jul 1, 2004 23:32 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 306 | $40.76 Strike: $0.00 | $12,472.56 |
DisclosureSEC source: 0001104659-04-018805 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,175 Underlying: common shares · 306 shares Expires not disclosed F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 01, 2004 Filed Jun 3, 2004 15:56 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 3,353 | $41.00 | $137,473.00 |
DisclosureSEC source: 0001104659-04-016080 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,144 Read SEC document |
| May 05, 2004 Filed Feb 1, 2005 17:21 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GiftCommon shares without par value | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,628 Read SEC document |
| May 03, 2004 Filed May 5, 2004 22:29 UTC |
FULLER H LAURANCEDirector
|
GrantStock equivalent units · Derivative | 2,652 | $42.32 Strike: $0.00 | $112,232.64 |
DisclosureSEC source: 0001104659-04-012715 · a4.xml · derivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,597 Underlying: common shares · 2,652 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · kind: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 03, 2004 Filed May 5, 2004 22:29 UTC |
SMITHBURG WILLIAM DDirector
|
GrantStock equivalent units · Derivative | 6,253 | $42.32 Strike: $0.00 | $264,626.96 |
DisclosureSEC source: 0001104659-04-012716 · a4.xml · derivative · entry 1 SMITHBURG WILLIAM D · CIK 0001190304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,335 Underlying: common shares · 6,253 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · kind: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 03, 2004 Filed May 5, 2004 22:30 UTC |
POWELL BOONE JRDirector
|
GrantStock equivalent units · Derivative | 4,442 | $42.32 Strike: $0.00 | $187,985.44 |
DisclosureSEC source: 0001104659-04-012717 · a4.xml · derivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,791 Underlying: common shares · 4,442 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 03, 2004 Filed May 5, 2004 22:30 UTC |
RAND A BARRYDirector
|
GrantStock equivalent units · Derivative | 37 | $42.32 Strike: $0.00 | $1,565.84 |
DisclosureSEC source: 0001104659-04-012718 · a4.xml · derivative · entry 1 RAND A BARRY · CIK 0001012979 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 631 Underlying: common shares · 37 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · kind: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 03, 2004 Filed May 5, 2004 22:31 UTC |
REYNOLDS W ANNDirector
|
GrantStock equivalent units · Derivative | 4,132 | $42.32 Strike: $0.00 | $174,866.24 |
DisclosureSEC source: 0001104659-04-012719 · a4.xml · derivative · entry 1 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,446 Underlying: common shares · 4,132 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · kind: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees and to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 03, 2004 Filed May 5, 2004 22:52 UTC |
WALTER JOHN RDirector
|
GrantStock equivalent units · Derivative | 1,722 | $42.32 Strike: $0.00 | $72,875.04 |
DisclosureSEC source: 0001104659-04-012727 · a4.xml · derivative · entry 1 WALTER JOHN R · CIK 0001046302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,722 Underlying: common shares · 1,722 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · kind: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director for the deferral of director fees. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. Read SEC document |
| May 03, 2004 Filed May 5, 2004 23:08 UTC |
OWEN DAVIDDirector
|
GrantStock equivalent units · Derivative | 339 | $42.32 Strike: $0.00 | $14,346.48 |
DisclosureSEC source: 0001104659-04-012728 · a4.xml · derivative · entry 1 OWEN DAVID · CIK 0001239142 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653 Underlying: common shares · 339 shares Expires not disclosed F1 · derivative.exercise_price: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · kind: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.exercise_date: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F1 · derivative.expiration_date: A stock equivalent unit account is maintained for the director to reflect accrued benefits under a prior retirement plan. These additional stock equivalent units were credited to that account. They resulted from the conversion into stock equivalent units of the deemed distribution of Hospira common stock, in connection with the spin-off of Hospira, Inc. from Abbott, based on the closing price of Abbott and Hospira common stock on May 3, 2004. Units are paid in cash. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| April 30, 2004 Filed May 4, 2004 20:43 UTC |
BEGLEY CHRISTOPHER BSenior Vice President
|
Tax withholdingCommon Shares | 7,591 | $41.47 | $314,760.82 |
DisclosureSEC source: 0001104659-04-012461 · a4.xml · nonDerivative · entry 3 BEGLEY CHRISTOPHER B · CIK 0001239420 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,484 F1 · balance_after: These are holdings as of Mr. Begley's last day as Abbott Laboratories' Senior Vice President, Hospital Products, as a result of the April 30, 2004 spin-off of Hospira, Inc. from Abbott Laboratories. Mr. Begley is Chief Executive Officer of Hospira, Inc. Read SEC document |
| April 30, 2004 Filed May 4, 2004 20:43 UTC |
BEGLEY CHRISTOPHER BSenior Vice President
|
Tax withholdingCommon Shares | 10,543 | $41.47 | $437,165.50 |
DisclosureSEC source: 0001104659-04-012461 · a4.xml · nonDerivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,075 Read SEC document |
| April 30, 2004 Filed May 4, 2004 20:43 UTC |
BEGLEY CHRISTOPHER BSenior Vice President
|
Tax withholdingCommon Shares | 3,506 | $41.47 | $145,376.29 |
DisclosureSEC source: 0001104659-04-012461 · a4.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,618 Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:05 UTC |
AUSTIN ROXANNE SDirector
|
GrantCommon shares without par value | 1,577 | $41.20 | $64,972.40 |
DisclosureSEC source: 0001104659-04-011388 · a4.xml · nonDerivative · entry 1 AUSTIN ROXANNE S · CIK 0001061632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,844 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:06 UTC |
GREENBERG JACK MDirector
|
GrantCommon shares without par value | 1,577 | $41.20 | $64,972.40 |
DisclosureSEC source: 0001104659-04-011390 · a4.xml · nonDerivative · entry 1 GREENBERG JACK M · CIK 0001074611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,844 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:05 UTC |
FULLER H LAURANCEDirector
|
GrantOption (right to buy) · Derivative | 6,699 | $0.00 Strike: $41.20 | $0.00 |
DisclosureSEC source: 0001104659-04-011389 · a4.xml · derivative · entry 2 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,699 Underlying: common shares · 6,699 shares Expires 2014-04-22 F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b). It contains a replacement option feature. Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:05 UTC |
FULLER H LAURANCEDirector
|
GrantCommon shares without par value | 1,577 | $41.20 | $64,972.40 |
DisclosureSEC source: 0001104659-04-011389 · a4.xml · nonDerivative · entry 1 FULLER H LAURANCE · CIK 0001187553 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,634 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| April 23, 2004 Filed Apr 27, 2004 19:07 UTC |
POWELL BOONE JRDirector
|
GrantCommon shares without par value | 1,577 | $41.20 | $64,972.40 |
DisclosureSEC source: 0001104659-04-011392 · a4.xml · nonDerivative · entry 1 POWELL BOONE JR · CIK 0001232973 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,707 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.